Status:
RECRUITING
Chronic Post-leptospirosis Manifestations in Reunion
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Leptospirosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Leptospirosis is a zoonosis caused by spirochetes, pathogenic bacteria of the genus Leptospira. It is transmitted to humans through mucocutaneous lesions by contact with water or soil contaminated by ...
Eligibility Criteria
Inclusion
- Adult or child subjects having been included in the COLEPT cohort with confirmed leptospirosis Where
- Adult subjects or children hospitalized for leptospirosis confirmed within 12-18 months before LEPTONIC inclusion;
- Be resident in Reunion
- Ability to answer a telephone questionnaire
- Benefit from a social security scheme
Exclusion
- Refusal of participation by the patient or his entourage if the patient is physically unable to give his opinion (coma, resuscitation, etc.).
- Exclusion or premature termination of participation in the COLEPT cohort
- Patient under judicial safeguard, guardianship or curatorship, under activated future protection mandate and family authorization
Key Trial Info
Start Date :
July 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 24 2026
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT05436756
Start Date
July 25 2022
End Date
July 24 2026
Last Update
August 31 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHOR
Saint-Paul, France
2
DIALLO
Saint-Pierre, France, 97410
3
GHER
Saint-Benoît, Reunion, 97470
4
CHU de la Réunion
Saint-Denis, Reunion, 97400